Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ITIL-168 |
Trade Name | |
Synonyms | ITIL 168|ITIL168 |
Drug Descriptions |
ITIL-168 is comprised of patient tumor derived tumor-infiltrating lymphocytes, which potentially induce killing of tumor cells (Journal for ImmunoTherapy of Cancer 2021;9; NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C182132 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ITIL-168 | ITIL-168 | 0 | 1 |
ITIL-168 + Pembrolizumab | ITIL-168 Pembrolizumab | 0 | 1 |